We are live on ! Find out more
WVP

Worth Venture Partners Portfolio holdings

AUM $31.6M
1-Year Est. Return 28.5%
This Fund
S&P 500
This Quarter Est. Return
-0.79%
1 Year Est. Return
+28.5%
3 Year Est. Return
+102.5%
5 Year Est. Return
+128.77%
10 Year Est. Return
–
AUM
$175M
AUM Growth
-$5.24M
Cap. Flow
-$107M
Cap. Flow %
-61.2%
Top 10 Hldgs %
71.4%
Holding
129
New
32
Increased
17
Reduced
29
Closed
29

Top Buys

Rank Stock Value
1
ILMN icon
Illumina
ILMN
+$2.18M
2
TDOC icon
Teladoc Health
TDOC
+$2.04M
3
WIFI
Boingo Wireless, Inc.
WIFI
+$1.41M
4
SONM icon
DNA X Inc
SONM
+$1.18M
5
NTNX icon
Nutanix
NTNX
+$1.04M

Top Sells

Rank Stock Value
1
COHR
Coherent Inc
COHR
+$2.53M
2
DZSI
DZS Inc. Common Stock
DZSI
+$1.96M
3
BKNG icon
Booking.com
BKNG
+$1.47M
4
MX icon
Magnachip Semiconductor
MX
+$1.2M
5
MU icon
Micron Technology
MU
+$1.1M

Sector Composition

Rank Sector Weight
1 Technology 7.73%
2 Healthcare 6.35%
3 Industrials 1.7%
4 Consumer Discretionary 0.17%
5 Communication Services 0%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
TTGT icon
51
TechTarget
TTGT
$327M
$225K 0.13%
9,993
-497
-5% -$11.4K
APVO icon
52
Aptevo Therapeutics
APVO
$4.96M
– –
0
– –
XPH icon
53
State Street SPDR S&P Pharmaceuticals ETF
XPH
$481M
$221K 0.13%
6,214
-797
-11% -$29.6K
XLP icon
54
State Street Consumer Staples Select Sector SPDR ETF
XLP
$14.6B
$206K 0.12%
3,347
-2,103
-39% -$126K
CORV
55
DELISTED
Correvio Pharma Corp. Ordinary Shares (Canada)
CORV
$203K 0.12%
101,364
+14,107
+16% +$28.6K
AGRX
56
DELISTED
Agile Therapeutics
AGRX
$195K 0.11%
+82
New +$202K
NTNX icon
57
CALL
Nutanix
NTNX
$16.1B
$188K 0.11%
+32,400
New +$764K
PGNX
58
DELISTED
Progenics Pharmaceuticals Inc
PGNX
$167K 0.1%
32,956
-105,401
-76% -$526K
NNDM
59
Nano Dimension
NNDM
$314M
$159K 0.09%
39,504
-12,962
-25% -$46.7K
APTO
60
DELISTED
Aptose Biosciences, Inc.
APTO
$131K 0.07%
+140
New +$159K
MDCO
61
PUT
DELISTED
Medicines Co
MDCO
$123K 0.07%
461,700
+30,600
+7% +$1.22M
ACAD icon
62
CALL
Acadia Pharmaceuticals
ACAD
$4.51B
$113K 0.06%
+12,000
New +$364K
ATEX icon
63
CALL
Anterix
ATEX
$1.72B
$91K 0.05%
+14,000
New +$590K
XLC icon
64
State Street Communication Services Select Sector SPDR ETF
XLC
$22.5B
$79K 0.05%
1,594
-470
-23% -$23.5K
BMRN icon
65
PUT
BioMarin Pharmaceuticals
BMRN
$11.9B
$78K 0.04%
27,000
+5,900
+28% +$454K
LOGM
66
CALL
DELISTED
LogMein, Inc.
LOGM
$77K 0.04%
+21,100
New +$1.51M
FOMX
67
DELISTED
Foamix Pharmaceuticals Ltd. Ordinary Shares
FOMX
$72K 0.04%
23,627
– –
BIIB icon
68
CALL
Biogen
BIIB
$30.9B
$65K 0.04%
+13,900
New +$3.24M
BNGO icon
69
Bionano Genomics
BNGO
$12.5M
$58K 0.03%
134
-12
-8% -$13.1K
FEED
70
ENvue Medical Inc
FEED
$2.01M
$50K 0.03%
9
– –
ENTX icon
71
Entera Bio
ENTX
$148M
$39K 0.02%
16,454
+442
+3% +$1.26K
GOSS icon
72
PUT
Gossamer Bio
GOSS
$101M
$29K 0.02%
+11,900
New +$237K
TVTX icon
73
PUT
Travere Therapeutics
TVTX
$5.17B
$26K 0.01%
107,400
-78,400
-42% -$1.3M
ACHV icon
74
Achieve Life Sciences
ACHV
$633M
$24K 0.01%
718
-2,871
-80% -$113K
SPY icon
75
PUT
State Street SPDR S&P 500 ETF Trust
SPY
$771B
$14K 0.01%
+22,900
New +$6.77M
1 2
3
4 5

Similar funds

VL
Vorpal LLC Nashville, Tennessee $32M AUM 10.89% 1-Year Est. Return
WTG
West Tower Group Richmond, Virginia $32.1M AUM 33.19% 1-Year Est. Return
QCA
Quantify Chaos Advisors Brooklyn, New York $32.1M AUM
SP
SCF Partners Houston, Texas $32.2M AUM 191.71% 1-Year Est. Return
OGC
One68 Global Capital New York $30.9M AUM
PE
Platinum Equity Beverly Hills, California $32.3M AUM 17.64% 1-Year Est. Return
RL
RPO LLC Stamford, Connecticut $32.3M AUM 14.17% 1-Year Est. Return
AIIC
AJU IB Investment Company Seoul, South Korea $30.5M AUM 128.96% 1-Year Est. Return

Worth Venture Partners's Q3 2019 Portfolio in Review

As of Q3 2019, Worth Venture Partners held 129 positions worth $175M, down 2.9% from $181M the previous quarter. Its ten largest holdings account for 71% of the portfolio.

Worth Venture Partners withdrew a net $107M in Q3 2019, closing 29 positions and reducing 29 holdings. Its most notable exit was Coherent Inc, an estimated $2.53M position sold in full.

By sector, the portfolio is most concentrated in Technology at 7.7% of assets, up from 7.6% a quarter earlier, followed by Healthcare and Industrials.

Against the trend, Worth Venture Partners opened a new position in Illumina worth $2.19M.

  • Worth Venture Partners's largest Q3 2019 buy was Illumina: 7,402 shares worth $2.19M.
  • Worth Venture Partners added most to La Jolla Pharmaceutical Company in Q3 2019, an estimated $258K increase.
  • Worth Venture Partners's biggest Q3 2019 reduction was Booking.com, cutting an estimated $1.47M.
  • Worth Venture Partners fully exited Coherent Inc in Q3 2019, selling an estimated $2.53M.
  • Worth Venture Partners's ten largest holdings make up 71% of its $175M portfolio in Q3 2019.
  • Worth Venture Partners opened 32 new positions and closed 29 in Q3 2019.
  • Worth Venture Partners's portfolio value fell 2.9% quarter-over-quarter to $175M.

Based on Worth Venture Partners's 13F filing for Q3 2019, filed 12 Nov 2019.